These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20578181)

  • 21. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium.
    Wadehra M; Forbes A; Pushkarna N; Goodglick L; Gordon LK; Williams CJ; Braun J
    Dev Biol; 2005 Nov; 287(2):336-45. PubMed ID: 16216233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial Gastric (Gastrointestinal)-type Mucinous Lesions: Report of a Series Illustrating the Spectrum of Benign and Malignant Lesions.
    Wong RW; Ralte A; Grondin K; Talia KL; McCluggage WG
    Am J Surg Pathol; 2020 Mar; 44(3):406-419. PubMed ID: 31567280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.
    Patel KS; Kejriwal S; Sun MM; Thammachantha S; Duong C; Chan A; Cherian N; Romiyo P; Gordon LK; Yong W; Wadehra M; Yang I
    J Neurooncol; 2020 Mar; 147(1):15-24. PubMed ID: 31981014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.
    Fu M; Maresh EL; Helguera GF; Kiyohara M; Qin Y; Ashki N; Daniels-Wells TR; Aziz N; Gordon LK; Braun J; Elshimali Y; Soslow RA; Penichet ML; Goodglick L; Wadehra M
    Mol Cancer Ther; 2014 Apr; 13(4):902-15. PubMed ID: 24448822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.
    Chen Q; Yao L; Burner D; Minev B; Lu L; Wang M; Ma W
    Clin Transl Oncol; 2019 Apr; 21(4):433-442. PubMed ID: 30218306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study.
    Li Y; Zhang X; Ge J; Liu X; Xu S; Zhu Z; Fang G; Liu J; Zhang H; Sun X
    Pathol Res Pract; 2016 Apr; 212(4):274-8. PubMed ID: 26839161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB and COX-2 expression in nonmalignant endometrial lesions and cancer.
    Faloppa CC; Baiocchi G; Cunha IW; Fregnani JH; Osorio CA; Fukazawa EM; Kumagai LY; Badiglian-Filho L; Pinto GL; Soares FA
    Am J Clin Pathol; 2014 Feb; 141(2):196-203. PubMed ID: 24436266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of Serum lncRNA DLEU1 Predicts Progression of Premalignant Endometrial Lesion and Unfavorable Clinical Outcome of Endometrial Cancer.
    Shan L; Zhao T; Wang Y
    Technol Cancer Res Treat; 2020; 19():1533033820965589. PubMed ID: 33327893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
    Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
    J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency.
    Williams CJ; Chu A; Jefferson WN; Casero D; Sudhakar D; Khurana N; Hogue CP; Aryasomayajula C; Patel P; Sullivan P; Padilla-Banks E; Mohandessi S; Janzen C; Wadehra M
    J Pathol; 2017 Jun; 242(2):246-259. PubMed ID: 28295343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
    Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
    Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Laminin Receptor 1 in Normal, Hyperplastic, and Malignant Endometrium.
    Kurdoglu M; Kucukaydin Z; Kurdoglu Z; Bulut G; Unlu Y; Ozen S
    Int J Gynecol Pathol; 2019 Jul; 38(4):326-334. PubMed ID: 30028353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
    Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
    J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
    Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
    Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.